Nerve Repair Co. Says Derivative Suit Lacks Demand Futility

Specialty medical product manufacturer Axogen Inc. sought dismissal of a derivative suit Tuesday, saying the investor behind it has not shown why it would have been futile to take concerns about a...

Already a subscriber? Click here to view full article